Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

PHASE3CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

December 31, 2005

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

Ciclesonide

Ciclesonide 200µg versus Placebo

DRUG

Placebo

placebo

Trial Locations (1)

Altana/Nycomed, San Antonio